Inhaled nitric oxide for moderate to severe COPD symptoms
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 40 and 75 years old
- Have a past smoking history of at least 10 pack-years and stopped smoking at least 1 month ago
- Have COPD confirmed by breathing tests: low airflow after using a bronchodilator (FEV1/FVC < 0.7 and FEV1 30% to 80% of predicted)
- Be able to sign consent and complete all required study visits and tests
- Not be pregnant or breastfeeding
- Not have had a COPD flare in the last month that required starting or increasing steroid pills
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early trial tests whether inhaled nitric oxide changes how well your lungs exchange gases during exercise in people with COPD, and compares results with healthy volunteers. It may help researchers understand lung blood-flow and breathing differences that could affect symptoms and exercise tolerance.
This Phase 2 trial tests whether sildenafil tablets can improve exercise ability, shortness of breath, and heart-lung function in people with COPD. It also compares against people without COPD to better understand how sildenafil affects breathing tests.
This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.
This trial tests whether giving nitric oxide gas through a breathing tube can improve oxygen levels in patients with severe obesity who are on a ventilator. It may help those whose lungs are struggling due to acute respiratory failure.
This trial tests whether breathing in nitric oxide gas can improve oxygen levels in adults with moderate to severe acute respiratory distress syndrome (a serious lung condition often caused by pneumonia or sepsis). If you have this condition and meet the requirements, you may be able to join.
This study tests an inhaled gas (iNO300) given through your breathing tube to improve oxygen levels in critically ill patients with pneumonia. You may qualify if you are on a ventilator and have been diagnosed with pneumonia within the last 3 days.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.